ImmunoScape Uses Machine Learning to Accurately Predict Antigen Specificity Based on T-Cell Phenotypes in New Peer-Reviewed Research
SAN DIEGO & SINGAPORE--(BUSINESS WIRE)--Oct 19, 2023--<a ...
SAN DIEGO & SINGAPORE--(BUSINESS WIRE)--Oct 19, 2023--<a ...
BRENTWOOD, Tenn. & PORT WENTWORTH, Ga.--(BUSINESS WIRE)--Oct 19, 2023--<a ...
CHICAGO--(BUSINESS WIRE)--Oct 19, 2023--MAIA Biotechnology, Inc. (NYSE American: MAIA), a clinical stage company developing telomere-targeting immunotherapies for cancer, today announced that preliminary safety and efficacy data from its ongoing Phase 2 clinical trial, THIO-101, was accepted ...
DUBLIN--(BUSINESS WIRE)--Oct 19, 2023--The <a ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Oct 19, 2023--<a ...
GENEVA, Switzerland--(BUSINESS WIRE)--Oct 19, 2023--GeNeuro (Euronext Paris: CH0308403085 - GNRO), a biopharmaceutical company developing novel treatments for neurodegenerative and autoimmune diseases, announced a collaboration with Verily, an Alphabet precision health technology company, to ...
